Why the study?
Are antiarrhythmic drugs safe and effective for managing maternal and fetal arrhythmias during pregnancy?
Are antiarrhythmic drugs safe and effective for managing maternal and fetal arrhythmias during pregnancy?
Antiarrhythmic drugs can be used to successfully treat most maternal and fetal arrhythmias during pregnancy, with a preference for drugs with established safety records and avoidance during the first trimester.
Answers are grounded in this paper and cite their sources.
Supports low-risk antiarrhythmic use after first trimester in pregnancy; leaves open need for prospective safety data.
During pregnancy a number of rhythm disturbances can occur in both the mother and fetus; these may range from benign ectopy to life-threatening arrhythmias. With a clear understanding of the maternal hemodynamic changes associated with pregnancy, and the appropriate antiarrhythmic therapies available, almost all such cases can be treated successfully. Although no drug is completely safe, most are well tolerated and can be given with relatively low risk. Drug therapy should be avoided during the first trimester of pregnancy if possible and drugs with the longest record of safety should be used as first-line therapy. Conservative therapies should be used when appropriate. Several drug options exist for most maternal and fetal arrhythmias.
No takes yet. Share an insight, caveat, or question.
Joglar et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: